XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net income (loss) $ (164,571,369) $ (446,085,413)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Change in unrealized (gain) loss on open commodity futures contracts 59,589,167 (62,259,521)
Change in unrealized (gain) loss on open swap contracts 14,904,042 2,004
(Increase) decrease in dividends receivable 2,440 (9,964)
(Increase) decrease in interest receivable 584,540 (2,305,658)
(Increase) decrease in prepaid insurance (130,637) (134,860)
(Increase) decrease in prepaid registration fees (128,580)  
(Increase) decrease in ETF transaction fees receivable (1,000) (1,000)
Increase (decrease) in payable due to Broker 677,814 35,614,331
Increase (decrease) in General Partner management fees payable (91,592) 297,775
Increase (decrease) in professional fees payable (369,803) (324,365)
Increase (decrease) in brokerage commissions payable   473
Increase (decrease) in directors' fees payable (1,771) 8,643
Increase (decrease) in license fees payable (8,089) 13,932
Net cash provided by (used in) operating activities (89,544,838) (475,183,623)
Cash Flows from Financing Activities:    
Addition of partnership shares 577,287,244 1,674,227,504
Redemption of partnership shares (596,036,697) (516,043,701)
Net cash provided by (used in) financing activities (18,749,453) 1,158,183,803
Net Increase (Decrease) in Cash and Cash Equivalents (108,294,291) 683,000,180
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 928,824,769 559,491,651
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period $ 820,530,478 $ 1,242,491,831